<DOC>
	<DOC>NCT02040259</DOC>
	<brief_summary>The purpose of the Trevo® Retriever Registry is to collect real world performance data of the Trevo Retriever which is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.</brief_summary>
	<brief_title>Trevo® Retriever Registry Post Market Surveillance</brief_title>
	<detailed_description>Trevo Retriever Registry is a prospective, open-label, consecutive enrollment, multi-center, international registry that may enroll a maximum of 2000 patients at up to 100 sites worldwide. Revascularization status will be assessed at the end of the procedure using the modified TICI (Thrombolysis in Cerebral Infarction)score. Additional data collection will include: 1. Day 90 mRS assessment 2. Day 90 all cause mortality 3. Neurological deterioration at 24 hours post procedure, defined as a four or more point increase in the NIHSS score from the baseline score 4. Rates of device and procedure related serious adverse events (AEs)</detailed_description>
	<criteria>Subjects experiencing acute ischemic stroke who are eligible for restoration of blood flow using any approved Trevo Retriever in the neurovasculature to remove thrombus Trevo Retriever is the initial mechanical neurothrombectomy device used to remove the thrombus Signed Informed Consent obtained Subject willing to comply with the protocol followup requirements Anticipated life expectancy of at least 3 months The subject is participating in another mechanical neurothrombectomy device trial or any other clinical trial where the study procedure or treatment might confound the study end point.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>mechanical thrombectomy device</keyword>
	<keyword>Retriever</keyword>
</DOC>